Sign in

CIK 0000730272

  • Large accelerated filer

REPLIGEN CORP

Sign in to watch
Ticker
RGEN
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
042729386
Phone
+1 781-449-9560
Business address
41 SEYON STREET, BUILDING 1, SUITE 100, WALTHAM, MA, 02453
  1. 4 Grant or award Director acquired 686 shares (grant or award)
  2. 4 Grant or award Director acquired 686 shares (grant or award)
  3. 4 Grant or award Director acquired 686 shares (grant or award)
  4. 4 Grant or award Director acquired 686 shares (grant or award)
  5. 4 Shares withheld for taxes Senior VP, R&D gave up 710 shares (to pay taxes)
  6. 4 Shares withheld for taxes See Remarks gave up 334 shares (to pay taxes)
  7. 4 Shares withheld for taxes Chief Financial Officer gave up 710 shares (to pay taxes)
  8. 4 Open-market buy Director bought 1,500 shares at an average $158.84 ($238,260)
  9. 3/A Insider 3/A
  10. 4 Shares withheld for taxes Chief Operating Officer gave up 334 shares (to pay taxes)
  11. 4 Shares withheld for taxes Chief Financial Officer gave up 3,674 shares (to pay taxes)
  12. 4 Shares withheld for taxes Senior VP, R&D gave up 1,247 shares (to pay taxes)
  13. 4 Shares withheld for taxes See Remarks gave up 126 shares (to pay taxes)
  14. 4 Shares withheld for taxes Chief Executive Officer gave up 8,244 shares (to pay taxes)
  15. 4 Shares withheld for taxes Chief Operating Officer gave up 210 shares (to pay taxes)
  16. 4 Shares withheld for taxes Chief Executive Officer gave up 9,418 shares (to pay taxes)
  17. 4 Shares withheld for taxes See Remarks gave up 1,090 shares (to pay taxes)
  18. 4 Shares withheld for taxes Senior VP, R&D gave up 358 shares (to pay taxes)
  19. 4 Shares withheld for taxes Chief Financial Officer gave up 521 shares (to pay taxes)
  20. 4 Shares withheld for taxes Chief Operating Officer gave up 594 shares (to pay taxes)

Page 8 of 34 · 669 filings